Dubash, S., Bryer, D., Fitton, J., Barr, A., Vandevelde, C., Marzo-Ortega, H., Freeston, J., 2019. Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis 19.. https://doi.org/10.7861/clinmedicine.19-2-s106